chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: bone ache; body shaking chills; no appetite; exhaustion; headache; occasional nausea; incapacitating fever; This is a spontaneous report from a contactable consumer, the patient. This 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9265),  dose  2 , single dose via an unspecified route of administration in the left arm on 02Feb2021 at 14:00 (at the age of 67 years-old) for COVID-19 vaccination. The patient was not pregnant.  Medical history included primary immunodeficiency, diabetes, irritable bowel disease, gastroesophageal reflux disease (GERD), high cholesterol and allergy to cefazolin (ANCEF). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3248, dose 1 on 12Jan2021 at 2:15 PM in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included famotidine, lansoprazole, pioglitazone and rosuvastatin. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. On 03Feb2021 at 09:00 AM, the patient experienced bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever. Treatment was not received for the events. The clinical outcome of  bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bone pain, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: bone ache; body shaking chills; no appetite; exhaustion; headache; occasional nausea; incapacitating fever; This is a spontaneous report from a contactable consumer, the patient. This 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9265),  dose  2 , single dose via an unspecified route of administration in the left arm on 02Feb2021 at 14:00 (at the age of 67 years-old) for COVID-19 vaccination. The patient was not pregnant.  Medical history included primary immunodeficiency, diabetes, irritable bowel disease, gastroesophageal reflux disease (GERD), high cholesterol and allergy to cefazolin (ANCEF). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3248, dose 1 on 12Jan2021 at 2:15 PM in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included famotidine, lansoprazole, pioglitazone and rosuvastatin. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. On 03Feb2021 at 09:00 AM, the patient experienced bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever. Treatment was not received for the events. The clinical outcome of  bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: bone ache; body shaking chills; no appetite; exhaustion; headache; occasional nausea; incapacitating fever; This is a spontaneous report from a contactable consumer, the patient. This 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9265),  dose  2 , single dose via an unspecified route of administration in the left arm on 02Feb2021 at 14:00 (at the age of 67 years-old) for COVID-19 vaccination. The patient was not pregnant.  Medical history included primary immunodeficiency, diabetes, irritable bowel disease, gastroesophageal reflux disease (GERD), high cholesterol and allergy to cefazolin (ANCEF). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3248, dose 1 on 12Jan2021 at 2:15 PM in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included famotidine, lansoprazole, pioglitazone and rosuvastatin. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. On 03Feb2021 at 09:00 AM, the patient experienced bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever. Treatment was not received for the events. The clinical outcome of  bone ache, body shaking chills, no appetite, exhaustion, headache, occasional nausea and incapacitating fever was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Taste disorder
Clinical narrative: Patient noted with complaint of feeling a foggy feeling, and having a "weird" taste in her mouth. BP 132/71 P 51 O2 sat 96 on RA. Patient was monitored for 30 minutes with no change in status. Consulted with RN, patient was taken to the ED at 11:57pm.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Paraesthesia oral, Rash, Rash erythematous, Rash pruritic
Clinical narrative: hives forming on chest; dizzy; tongue started feeling very heavy; This is a spontaneous report from a contactable consumer, reporting for herself. A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6201), via an unspecified route of administration at the left arm on 22Feb2021 14:30 at a single dose for COVID-19 immunization. Vaccination was done in a Public Health Department. The patient medical history was not reported. The patient was not pregnant. No other vaccine was received in four weeks. Concomitant medication included zinc sulfate (ZINC), magnesium and vitamin D NOS. The patient previously took amoxicillin and experienced known allergies: amoxicillin. The patient experienced tongue started feeling very heavy on 22Feb2021, dizzy on 22Feb2021 14:40 and hives forming on chest on 22Feb2021 14:45 and was hospitalized on 22Feb2021. The patient started feeling dizzy within the first ten minutes. Noticed hives forming on chest at around the fifteen-minute mark. The nurse insisted on observing her for thirty minutes. Around thirty-five minutes, her tongue started feeling very heavy. Nurse on site administered an Epi pen and she was sent to the hospital for observation. Treatment included famotidine, dexamethasone, diphenhydramine, s.chlori (as reported). It was unknown if the patient had COVID prior to vaccination. The patient was not COVID tested post vaccination. The outcome of the events was recovering.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat clearing
Clinical narrative: hives forming on chest; dizzy; tongue started feeling very heavy; This is a spontaneous report from a contactable consumer, reporting for herself. A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6201), via an unspecified route of administration at the left arm on 22Feb2021 14:30 at a single dose for COVID-19 immunization. Vaccination was done in a Public Health Department. The patient medical history was not reported. The patient was not pregnant. No other vaccine was received in four weeks. Concomitant medication included zinc sulfate (ZINC), magnesium and vitamin D NOS. The patient previously took amoxicillin and experienced known allergies: amoxicillin. The patient experienced tongue started feeling very heavy on 22Feb2021, dizzy on 22Feb2021 14:40 and hives forming on chest on 22Feb2021 14:45 and was hospitalized on 22Feb2021. The patient started feeling dizzy within the first ten minutes. Noticed hives forming on chest at around the fifteen-minute mark. The nurse insisted on observing her for thirty minutes. Around thirty-five minutes, her tongue started feeling very heavy. Nurse on site administered an Epi pen and she was sent to the hospital for observation. Treatment included famotidine, dexamethasone, diphenhydramine, s.chlori (as reported). It was unknown if the patient had COVID prior to vaccination. The patient was not COVID tested post vaccination. The outcome of the events was recovering.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Tongue disorder, Urticaria
Clinical narrative: hives forming on chest; dizzy; tongue started feeling very heavy; This is a spontaneous report from a contactable consumer, reporting for herself. A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6201), via an unspecified route of administration at the left arm on 22Feb2021 14:30 at a single dose for COVID-19 immunization. Vaccination was done in a Public Health Department. The patient medical history was not reported. The patient was not pregnant. No other vaccine was received in four weeks. Concomitant medication included zinc sulfate (ZINC), magnesium and vitamin D NOS. The patient previously took amoxicillin and experienced known allergies: amoxicillin. The patient experienced tongue started feeling very heavy on 22Feb2021, dizzy on 22Feb2021 14:40 and hives forming on chest on 22Feb2021 14:45 and was hospitalized on 22Feb2021. The patient started feeling dizzy within the first ten minutes. Noticed hives forming on chest at around the fifteen-minute mark. The nurse insisted on observing her for thirty minutes. Around thirty-five minutes, her tongue started feeling very heavy. Nurse on site administered an Epi pen and she was sent to the hospital for observation. Treatment included famotidine, dexamethasone, diphenhydramine, s.chlori (as reported). It was unknown if the patient had COVID prior to vaccination. The patient was not COVID tested post vaccination. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Haemorrhage, Herpes zoster, Immune thrombocytopenia, Immunoglobulin therapy
Clinical narrative: Varicella zoster on 1/7 Acute thrombocytopenia symptoms 1/10 Admitted to hospital with platelets 0, WBC 6, Hgb 13.  received IVIG x2 days, high dose dexamethasone, then 5 weeks of prednisone with improvement in platelets.  Did not return to normal range until 3/1/2021.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Platelet count decreased
Clinical narrative: Varicella zoster on 1/7 Acute thrombocytopenia symptoms 1/10 Admitted to hospital with platelets 0, WBC 6, Hgb 13.  received IVIG x2 days, high dose dexamethasone, then 5 weeks of prednisone with improvement in platelets.  Did not return to normal range until 3/1/2021.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Immunoglobulin therapy, Platelet count decreased, Thrombocytopenia, White blood cell count decreased
Clinical narrative: Varicella zoster on 1/7 Acute thrombocytopenia symptoms 1/10 Admitted to hospital with platelets 0, WBC 6, Hgb 13.  received IVIG x2 days, high dose dexamethasone, then 5 weeks of prednisone with improvement in platelets.  Did not return to normal range until 3/1/2021.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis
Clinical narrative: tired; sore arm; Facial droop (left eye and mouth); This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration at left arm 23Feb2021 08:00 at single dose for covid-19 immunisation. Medical history included Known allergies: Sulfa drugs, codeine, diastolic dysfunction type 1 from Jul2020, and anxiety depressive disorder (she took a medication for that and it had been diagnosed more than ten years). Concomitant medication included bupropion hydrochloride, naltrexone hydrochloride (CONTRAVE). The patient experienced facial droop (left eye and mouth) on 23Feb2021 14:30, tired and sore arm on an unspecified date. The clinical course was as following: She said her appointment for the vaccine was at 08:00AM, and around 02:30PM she was in a video meeting and her left side of her face started to droop and her coworker messaged her to ask if she was ok since she looked pretty funny with the eye and mouth droop. She said that this droop lasted about 4 hours and by 06:30PM it was mostly resolved, if she was not looking at it or trying to raise her eyebrows. She said that the only other side effects were she was tired and had a sore arm. She said doctor asked her to got to the emergency room (ER) to rule out a stroke or transient ischemic attack (TIA) so they did a couple of Computerised tomogram (CT) scans, one with contrast and one without, and a MRI and they did full blood lab work up, and did an Electrocardiogram (EKG) to rule out central nervous system events. She says that they didn't think it was a TIA, they felt it was a peripheral nervous event related to an autoimmune response and all the tests said that they did not thought she had TIA event. She said doctor said it was likely an auto immune response to receiving vaccine, since there were no intervening events between getting the vaccine and the droop, she has not been sick or had any dental events recently. the main reason she was calling was to see if she should get the second dose, since she wanted to get it but has heard the side effects can be stronger for the second dose. She says she would like to know can she or should she take it. The patient was tested was for a stroke but that test came back negative. The patient would like to know if it is contraindicated for her to receive the second dose after having this reaction. The outcome of the event Facial droop was recovering, and the outcome of the event tired and sore arm was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Facial paralysis, Fatigue
Clinical narrative: tired; sore arm; Facial droop (left eye and mouth); This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration at left arm 23Feb2021 08:00 at single dose for covid-19 immunisation. Medical history included Known allergies: Sulfa drugs, codeine, diastolic dysfunction type 1 from Jul2020, and anxiety depressive disorder (she took a medication for that and it had been diagnosed more than ten years). Concomitant medication included bupropion hydrochloride, naltrexone hydrochloride (CONTRAVE). The patient experienced facial droop (left eye and mouth) on 23Feb2021 14:30, tired and sore arm on an unspecified date. The clinical course was as following: She said her appointment for the vaccine was at 08:00AM, and around 02:30PM she was in a video meeting and her left side of her face started to droop and her coworker messaged her to ask if she was ok since she looked pretty funny with the eye and mouth droop. She said that this droop lasted about 4 hours and by 06:30PM it was mostly resolved, if she was not looking at it or trying to raise her eyebrows. She said that the only other side effects were she was tired and had a sore arm. She said doctor asked her to got to the emergency room (ER) to rule out a stroke or transient ischemic attack (TIA) so they did a couple of Computerised tomogram (CT) scans, one with contrast and one without, and a MRI and they did full blood lab work up, and did an Electrocardiogram (EKG) to rule out central nervous system events. She says that they didn't think it was a TIA, they felt it was a peripheral nervous event related to an autoimmune response and all the tests said that they did not thought she had TIA event. She said doctor said it was likely an auto immune response to receiving vaccine, since there were no intervening events between getting the vaccine and the droop, she has not been sick or had any dental events recently. the main reason she was calling was to see if she should get the second dose, since she wanted to get it but has heard the side effects can be stronger for the second dose. She says she would like to know can she or should she take it. The patient was tested was for a stroke but that test came back negative. The patient would like to know if it is contraindicated for her to receive the second dose after having this reaction. The outcome of the event Facial droop was recovering, and the outcome of the event tired and sore arm was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Pain in extremity
Clinical narrative: tired; sore arm; Facial droop (left eye and mouth); This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration at left arm 23Feb2021 08:00 at single dose for covid-19 immunisation. Medical history included Known allergies: Sulfa drugs, codeine, diastolic dysfunction type 1 from Jul2020, and anxiety depressive disorder (she took a medication for that and it had been diagnosed more than ten years). Concomitant medication included bupropion hydrochloride, naltrexone hydrochloride (CONTRAVE). The patient experienced facial droop (left eye and mouth) on 23Feb2021 14:30, tired and sore arm on an unspecified date. The clinical course was as following: She said her appointment for the vaccine was at 08:00AM, and around 02:30PM she was in a video meeting and her left side of her face started to droop and her coworker messaged her to ask if she was ok since she looked pretty funny with the eye and mouth droop. She said that this droop lasted about 4 hours and by 06:30PM it was mostly resolved, if she was not looking at it or trying to raise her eyebrows. She said that the only other side effects were she was tired and had a sore arm. She said doctor asked her to got to the emergency room (ER) to rule out a stroke or transient ischemic attack (TIA) so they did a couple of Computerised tomogram (CT) scans, one with contrast and one without, and a MRI and they did full blood lab work up, and did an Electrocardiogram (EKG) to rule out central nervous system events. She says that they didn't think it was a TIA, they felt it was a peripheral nervous event related to an autoimmune response and all the tests said that they did not thought she had TIA event. She said doctor said it was likely an auto immune response to receiving vaccine, since there were no intervening events between getting the vaccine and the droop, she has not been sick or had any dental events recently. the main reason she was calling was to see if she should get the second dose, since she wanted to get it but has heard the side effects can be stronger for the second dose. She says she would like to know can she or should she take it. The patient was tested was for a stroke but that test came back negative. The patient would like to know if it is contraindicated for her to receive the second dose after having this reaction. The outcome of the event Facial droop was recovering, and the outcome of the event tired and sore arm was unknown.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Throat irritation
Clinical narrative: Patient experienced itchy/scratchy throat after receiving second dose of Covid vaccine. No other signs of distress.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal discomfort, Throat irritation
Clinical narrative: Patient experienced itchy/scratchy throat after receiving second dose of Covid vaccine. No other signs of distress.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, External ear pain, Headache, Injection site pain, Muscle tightness
Clinical narrative: Vaccine was given at state assigned facility on 2/24.  Pt first seen on 2/26 and reports she has been experienced shooting pain up and down her right arm. She has tension and numbness in right hand. Notes right hand was swollen. She is having right sided occipital head aches. pt also reports pain to right shoulder and neck, which causes her limited ROM due to pain.   symptoms started 24 hrs after vaccination and have persisted for 14 days after immunization.  She took ibuprofen x1.  Flexeril 5mg and physical therapy ordered.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pain, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: Vaccine was given at state assigned facility on 2/24.  Pt first seen on 2/26 and reports she has been experienced shooting pain up and down her right arm. She has tension and numbness in right hand. Notes right hand was swollen. She is having right sided occipital head aches. pt also reports pain to right shoulder and neck, which causes her limited ROM due to pain.   symptoms started 24 hrs after vaccination and have persisted for 14 days after immunization.  She took ibuprofen x1.  Flexeril 5mg and physical therapy ordered.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Hypoaesthesia, Joint range of motion decreased, Neck pain
Clinical narrative: Vaccine was given at state assigned facility on 2/24.  Pt first seen on 2/26 and reports she has been experienced shooting pain up and down her right arm. She has tension and numbness in right hand. Notes right hand was swollen. She is having right sided occipital head aches. pt also reports pain to right shoulder and neck, which causes her limited ROM due to pain.   symptoms started 24 hrs after vaccination and have persisted for 14 days after immunization.  She took ibuprofen x1.  Flexeril 5mg and physical therapy ordered.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling, Tension
Clinical narrative: Vaccine was given at state assigned facility on 2/24.  Pt first seen on 2/26 and reports she has been experienced shooting pain up and down her right arm. She has tension and numbness in right hand. Notes right hand was swollen. She is having right sided occipital head aches. pt also reports pain to right shoulder and neck, which causes her limited ROM due to pain.   symptoms started 24 hrs after vaccination and have persisted for 14 days after immunization.  She took ibuprofen x1.  Flexeril 5mg and physical therapy ordered.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye irritation, Eye pruritus, Headache, Hyperhidrosis, Nausea
Clinical narrative: 20 minutes after receiving COVID-19 vaccine at the Vaccination Site, she experienced headache, burning sensation of shoulder blade & right arm, red splotches & itching of upper chest, eyes burning & itching, right jaw pain, redness of both arms and was diaphoretic. Seen by paramedics on site but refused to go to the ER. Stated she would take Benadryl when she got home. Self administered 2 Benadryl when arrived home and again at 8pm. Felt better the next day with only itching.  Informed by agency to contact health department to report event instead of coming into the office to be evaluated.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Rash, Rash pruritic, Skin burning sensation
Clinical narrative: 20 minutes after receiving COVID-19 vaccine at the Vaccination Site, she experienced headache, burning sensation of shoulder blade & right arm, red splotches & itching of upper chest, eyes burning & itching, right jaw pain, redness of both arms and was diaphoretic. Seen by paramedics on site but refused to go to the ER. Stated she would take Benadryl when she got home. Self administered 2 Benadryl when arrived home and again at 8pm. Felt better the next day with only itching.  Informed by agency to contact health department to report event instead of coming into the office to be evaluated.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Erythema, Eye irritation, Eye pruritus, Headache
Clinical narrative: 20 minutes after receiving COVID-19 vaccine at the Vaccination Site, she experienced headache, burning sensation of shoulder blade & right arm, red splotches & itching of upper chest, eyes burning & itching, right jaw pain, redness of both arms and was diaphoretic. Seen by paramedics on site but refused to go to the ER. Stated she would take Benadryl when she got home. Self administered 2 Benadryl when arrived home and again at 8pm. Felt better the next day with only itching.  Informed by agency to contact health department to report event instead of coming into the office to be evaluated.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Pain in jaw, Pruritus, Rash macular
Clinical narrative: 20 minutes after receiving COVID-19 vaccine at the Vaccination Site, she experienced headache, burning sensation of shoulder blade & right arm, red splotches & itching of upper chest, eyes burning & itching, right jaw pain, redness of both arms and was diaphoretic. Seen by paramedics on site but refused to go to the ER. Stated she would take Benadryl when she got home. Self administered 2 Benadryl when arrived home and again at 8pm. Felt better the next day with only itching.  Informed by agency to contact health department to report event instead of coming into the office to be evaluated.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Swollen tongue, Urticaria
Clinical narrative: No current pregnancy. Hives, itching, shortness of breath, light headed, numbness/tingling in extremities, thick/numb feeling in tongue, coughing.  taken to ED and given IV Benadryl and oral prednisone.  Given prescription of for prednisone and Zyrtec for home use. At home, shortness of breath with coughing, lightheadedness, numbness/tingling  in extremities, itching persisted for the next  5days. Took prednisone as prescribed for 3 days. Did not take allergy medication. Three days later on Thursday 2/22, I fell while going down stairs and suffered a badly sprained ankle.  I feel the fall is a result of lingering symptoms of the vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dizziness, Dyspnoea, Fall, Hypoaesthesia
Clinical narrative: No current pregnancy. Hives, itching, shortness of breath, light headed, numbness/tingling in extremities, thick/numb feeling in tongue, coughing.  taken to ED and given IV Benadryl and oral prednisone.  Given prescription of for prednisone and Zyrtec for home use. At home, shortness of breath with coughing, lightheadedness, numbness/tingling  in extremities, itching persisted for the next  5days. Took prednisone as prescribed for 3 days. Did not take allergy medication. Three days later on Thursday 2/22, I fell while going down stairs and suffered a badly sprained ankle.  I feel the fall is a result of lingering symptoms of the vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Ligament sprain, Paraesthesia, Pruritus, Urticaria
Clinical narrative: No current pregnancy. Hives, itching, shortness of breath, light headed, numbness/tingling in extremities, thick/numb feeling in tongue, coughing.  taken to ED and given IV Benadryl and oral prednisone.  Given prescription of for prednisone and Zyrtec for home use. At home, shortness of breath with coughing, lightheadedness, numbness/tingling  in extremities, itching persisted for the next  5days. Took prednisone as prescribed for 3 days. Did not take allergy medication. Three days later on Thursday 2/22, I fell while going down stairs and suffered a badly sprained ankle.  I feel the fall is a result of lingering symptoms of the vaccine.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Nausea, Pain, Pyrexia
Clinical narrative: High fever (102 Fahrenheit); body aches; chills; severe headache; nausea; This is a spontaneous report from a contactable consumer (patient himself). A 41-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Feb2021 (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization.  The patient medical history reported as none and no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination.  The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Feb2021 10:15 AM (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization and experienced Body aches, joint pain, and intermittent nausea. These symptoms started approximately 8 hours after the shot and persisted for 48 hours. The patient experienced high fever (102 fahrenheit), body aches, chills, severe headache, nausea on 25Feb2021 22:00.  These intense symptoms began approximately 12 hours after the 2nd shot and are currently on-going. These events did not result in emergency room visit or physician office visit.  It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 Since the vaccination. The patient underwent lab tests and procedures which included body temperature: 102 fahrenheit on 25Feb2021.  No treatment received for the adverse events. The outcome of the events was not resolved.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021213613 same reporter/patient/drug, different time/event
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pain
Clinical narrative: High fever (102 Fahrenheit); body aches; chills; severe headache; nausea; This is a spontaneous report from a contactable consumer (patient himself). A 41-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Feb2021 (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization.  The patient medical history reported as none and no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination.  The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Feb2021 10:15 AM (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization and experienced Body aches, joint pain, and intermittent nausea. These symptoms started approximately 8 hours after the shot and persisted for 48 hours. The patient experienced high fever (102 fahrenheit), body aches, chills, severe headache, nausea on 25Feb2021 22:00.  These intense symptoms began approximately 12 hours after the 2nd shot and are currently on-going. These events did not result in emergency room visit or physician office visit.  It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 Since the vaccination. The patient underwent lab tests and procedures which included body temperature: 102 fahrenheit on 25Feb2021.  No treatment received for the adverse events. The outcome of the events was not resolved.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021213613 same reporter/patient/drug, different time/event
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: High fever (102 Fahrenheit); body aches; chills; severe headache; nausea; This is a spontaneous report from a contactable consumer (patient himself). A 41-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Feb2021 (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization.  The patient medical history reported as none and no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination.  The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Feb2021 10:15 AM (at age of 41-year-old) (Lot number: EL3247, expiry: May2021), at single dose in Left arm for COVID-19 immunization and experienced Body aches, joint pain, and intermittent nausea. These symptoms started approximately 8 hours after the shot and persisted for 48 hours. The patient experienced high fever (102 fahrenheit), body aches, chills, severe headache, nausea on 25Feb2021 22:00.  These intense symptoms began approximately 12 hours after the 2nd shot and are currently on-going. These events did not result in emergency room visit or physician office visit.  It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 Since the vaccination. The patient underwent lab tests and procedures which included body temperature: 102 fahrenheit on 25Feb2021.  No treatment received for the adverse events. The outcome of the events was not resolved.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021213613 same reporter/patient/drug, different time/event
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acne, Antinuclear antibody, Blood test, C-reactive protein, Cellulitis
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Complement factor C3, Complement factor C4, Differential white blood cell count, Eye pain, Full blood count
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster, Lacrimation increased, Lipids, Metabolic function test, Ophthalmic herpes zoster
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic, Rheumatoid factor, Swelling face
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Swelling of eyelid, Urine analysis, Urine protein/creatinine ratio, Vomiting, White blood cell count
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, C-reactive protein, Full blood count, Hypoaesthesia, Lipids
Clinical narrative: I received the 1st dose of the Moderna Vaccine on January 6, 2021 at 01:49 pm. Approximately 4.5 hours later on January 6, 2021, I went outside in the cold temperatures. Upon returning inside to warmer air, the bilateral fingertips of both hands were pale white, numb, and painful. The time was 06:30 pm on January 6, 2021. At 06:47 pm, I felt a different feeling in the bilateral tips of my fingertips, and could see the color changing from pale white to a mixture of purple/black.  January 6, 2021 at 06:32 pm was the first time I have ever had my hands respond in this manner to cold temperatures. I have felt one fingertip go numb and turn white for a split second, only one time in my life but it was not a repeat occurrence, and it only lasted for about a second when it occurred. This experience and reaction I currently have lasts from 15-30 minutes of bilateral fingertip numbness and discoloration with pain. The bilateral fingertips of both hands now respond in this manner every time they are exposed to cold temperatures. I signed up for V-Safe and did state that I was having this symptom through the Vaccine reporting system on V-Safe under ?other'' multiple times. Treatment I received from a health provider are as follows; I had a telemedicine visit on January 14, 2021 at 12:51 pm to address my concern of ?reaction to Covid vaccine, fingertips were numb, lasting 30 mins?. On 1/14/2021, I received a primary diagnosis of Raynaud's Syndrome by my Primary Care Provider.  On 1/28/2021, I was seen in person by my Primary Care Provider for a Well Visit to complete a physical with my primary care provider. I was provided with a referral to a Rheumatologist for further advice about receiving the additional second Covid vaccination in the series. I also was ordered to do lab work. On 2/2/2021, I was seen by a Rheumatologist for new diagnosis of Raynaud?s Syndrome, and advised that risk outweighed the benefits in regards to receiving the second vaccination in the Moderna Covid-19 series.